These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 1880932
1. [Combined antibacterial activity of aztreonam and clindamycin against clinically isolated strains]. Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R, Oda S. Jpn J Antibiot; 1991 May; 44(5):529-37. PubMed ID: 1880932 [Abstract] [Full Text] [Related]
2. [Susceptibility of clinical isolates to aztreonam]. Nagasawa Z, Nishimura T, Nagumo F, Ueda H, Tadano J, Katoh O, Yamada H. Jpn J Antibiot; 1989 Jun; 42(6):1257-70. PubMed ID: 2507799 [Abstract] [Full Text] [Related]
10. [Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders]. Urabe A, Takaku F, Mizoguchi H, Nomura T, Aoki N, Yamaguchi H, Mutoh Y, Miura Y, Toyama K, Hirashima K. Jpn J Antibiot; 1990 Oct; 43(10):1713-22. PubMed ID: 2086813 [Abstract] [Full Text] [Related]
11. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics. Qadri SM, Belobraydic KA. Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346 [Abstract] [Full Text] [Related]
15. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria]. Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T. Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920 [Abstract] [Full Text] [Related]
16. [Susceptibility of clinical isolates to aztreonam]. Asari S, Horikawa M, Tsukamoto H, Kouda K, Hayashi C, Miyai K. Jpn J Antibiot; 1987 Jul; 40(7):1317-31. PubMed ID: 3479624 [Abstract] [Full Text] [Related]
17. [Combination antibacterial effects between aztreonam and eight other antibiotics]. Nishino T, Obana Y, Kuzui H, Murakami T. Jpn J Antibiot; 1991 Jan; 44(1):1-8. PubMed ID: 1904106 [Abstract] [Full Text] [Related]
18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution]. Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H. Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754 [Abstract] [Full Text] [Related]
19. [Susceptibilities of clinical isolates to antibacterial agents. A study mainly focused on ofloxacin (the second report). Reported by the Research Group for Testing ofloxacin Susceptibility on Clinical Isolates]. Kosakai N. Jpn J Antibiot; 1989 May; 42(5):1125-65. PubMed ID: 2664255 [Abstract] [Full Text] [Related]